Expression of regulatory proteins in choroid plexus changes in early stages of Alzheimer disease

Journal of Neuropathology and Experimental Neurology
Agnieszka KrzyzanowskaEva Carro

Abstract

Recent studies indicate that the choroid plexus has important physiologic and pathologic roles in Alzheimer disease (AD). To obtain additional insight on choroid plexus function, we performed a proteomic analysis of choroid plexus samples from patients with AD stages I to II (n = 16), III to IV (n = 16), and V to VI (n = 11) and 7 age-matched control subjects. We used 2-dimensional differential gel electrophoresis coupled with mass spectrometry to generate a complete picture of changes in choroid plexus protein expression occurring in AD patients. We identified 6 proteins: 14-3-3 β/α, 14-3-3 ε, moesin, proteasome activator complex subunit 1, annexin V, and aldehyde dehydrogenase, which were significantly regulated in AD patient samples (p < 0.05, >1.5-fold variation in expression vs control samples). These proteins are implicated in major physiologic functions including mitochondrial dysfunction and apoptosis regulation. These findings contribute additional significance to the emerging importance of molecular and functional changes of choroid plexus function in the pathophysiology of AD.

References

Feb 12, 1998·Experimental Brain Research·E M CornfordM J Raleigh
Jun 15, 2000·Journal of Neurochemistry·J N KellerW R Markesbery
Jan 3, 2001·Microscopy Research and Technique·J E Preston
Jul 11, 2001·Journal of Neuropathology and Experimental Neurology·M J PickloT J Montine
Sep 29, 2001·The Journal of Biological Chemistry·S C Masters, H Fu
Oct 13, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M J van HemertG P van Heusden
Oct 26, 2005·Experimental Biology and Medicine·Janelle S CrossgroveWei Zheng
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eva CarroIgnacio Torres-Aleman
Nov 4, 2006·Science·Michel Goedert, Maria Grazia Spillantini
Feb 28, 2007·Neurobiology of Aging·Marcelo O DietrichEva Carro
Aug 10, 2007·Nature·Eric J BennettRon R Kopito
Jul 15, 2009·Acta Neuropathologica·Ester Perez-GraciaIsidro Ferrer
Dec 25, 2009·Acta Neuropathologica·Hartwig Wolburg, Werner Paulus
Aug 26, 2010·Current Aging Science·Ximena Alvira-Botero, Eva M Carro
Oct 16, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Mark M EwingPaul H A Quax
May 9, 2012·Frontiers in Pharmacology·Agnieszka Krzyzanowska, Eva Carro
Jun 5, 2012·Frontiers in Cellular Neuroscience·Sandro D MesquitaFernanda Marques
Jan 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Enrico CristanteEgle Solito
Apr 12, 2013·Frontiers in Aging Neuroscience·Hitoshi SohmaYasuo Kokai
Jun 27, 2013·Molecular Neurodegeneration·Christoffer RosénHenrik Zetterberg
Oct 24, 2013·Molecular Neurodegeneration·Fernanda MarquesJoana Almeida Palha
Aug 26, 2014·Progress in Molecular Biology and Translational Science·Kristina Friedland-LeunerWalter E Müller

❮ Previous
Next ❯

Citations

Mar 16, 2018·Oncotarget·Maria Garranzo-AsensioRodrigo Barderas
Jul 1, 2019·Journal of Alzheimer's Disease : JAD·Lilian Calderón-GarcidueñasRicardo Torres-Jardón
Apr 4, 2021·Proteomes·Ankit P Jain, Gajanan Sathe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

© 2022 Meta ULC. All rights reserved